SarahPatriciaPsutkaMDMSc

Urology • Seattle, WA

Minimally Invasive Surgery, Surgical Oncology

Assistant Professor of Urology, University of Washington, Seattle Cancer Care Alliance

Join to view full profile

Dr. Psutka is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Psutka's full profile

Already have an account?

Office
1959 NE Pacific St
Seattle, WA 98195
Phone+1 206-520-5000

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Minimally Invasive Urologic Surgery, 2013 - 2015
Massachusetts General Hospital/Harvard Medical SchoolResidency, Urology, 2009 - 2012
Massachusetts General HospitalResidency, Surgery, 2007 - 2009
Harvard Medical SchoolClass of 2007

Certifications & Licensure

WA State Medical License 2018 - 2027
AK State Medical License 2022 - 2026
OR State Medical License 2022 - 2025
IL State Medical License 2015 - 2020
MA State Medical License 2012 - 2019
MN State Medical License 2013 - 2016
American Board of Urology Urology

Publications & Presentations

PubMed

Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG).
Roberto Contieri, Mark S Soloway, Paolo Gontero, Harry Herr, Wassim Kassouf
European Urology Oncology. 2025-02-01
Artificial Intelligence-Based Assessment of Preoperative Body Composition Is Associated With Early Complications After Radical Cystectomy.
Vidit Sharma, Anthony Fadel, Matthew K Tollefson, Sarah P Psutka, Daniel J Blezek
The Journal of Urology. 2025-02-01
Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer.
Siamak Daneshmand, Ashish M Kamat, Neal D Shore, Joshua J Meeks, Matthew D Galsky
Urologic Oncology. 2025-01-15

Lectures

Cytoreductive Nephrectomy Still an Important Tool in Management of Metastatic Renal Cell Carcinoma
ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Press Mentions

Fred Hutch at ASCO: New Insights on Financial Toxicity, Combination Therapies for Cancer and the Need for Targeted Breast Cancer Therapies in UgandaMay 26th, 2023
You and Your BladderMay 4th, 2022
'No Slack in the System': Struggling Hospitals Despair at Prospect of Omicron WaveDecember 21st, 2021
Join now to see all

Grant Support

Predicting Functional Decline and Clinical Outcomes in Newly Diagnosed Older Patients with Localized Bladder CancerUNIVERSITY OF WASHINGTON2022–2025